Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease?
Postmenopausal hormone replacement therapy (HRT) with oral oestrogen was predicted to reduce coronary heart disease (CHD) risk by 50%. Randomized controlled trials show no such benefit, however, pointing instead to an initial increase in CHD events. Although the cardiovascular effects of transdermal...
Збережено в:
| Опубліковано в:: | Curr Control Trials Cardiovasc Med |
|---|---|
| Автор: | |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2001
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59529/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806798/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-5-211 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|